• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Surfactant abnormalities and adult respiratory failure.

作者信息

Seeger W, Pison U, Buchhorn R, Obertacke U, Joka T

机构信息

Department of Internal Medicine, Justus-Liebig University, Giessen, Federal Republic of Germany.

出版信息

Lung. 1990;168 Suppl:891-902. doi: 10.1007/BF02718225.

DOI:10.1007/BF02718225
PMID:2117209
Abstract

Surfactant abnormalities have been implicated in the development of the acute respiratory distress syndrome in adults. Experimental studies show that surfactant inhibition by protein-leak into the alveolar space is of major importance under these circumstances. Fibrin(ogen)-surfactant-interaction appears to contribute to disturbances of surfactant function with subsequent alveolar instability and ventilation-perfusion-mismatch. In a prospective study in severely injured patients, the surfactant in serially obtained bronchoalveolar lavage fluids was investigated. An early leakage of plasma proteins into the alveolar space was noted in those patients, who developed severe ARDS. Moreover, deterioration of surfactant function was markedly more pronounced in those patients than in trauma victims who developed only mild pulmonary dysfunction. In addition to the protein-leakage, a progressive decrease of the surfactant-specific dipalmitoyl-phosphatidylcholine was noted, significantly correlated with the deterioration of surfactant function and the severity of respiratory failure. In conclusion, experimental and clinical studies show surfactant abnormalities in the adult respiratory distress syndrome. Plasma protein-leakage and progressive alteration of alveolar type II surfactant secretion appear to be of major importance.

摘要

相似文献

1
Surfactant abnormalities and adult respiratory failure.
Lung. 1990;168 Suppl:891-902. doi: 10.1007/BF02718225.
2
Surfactant abnormalities in patients with respiratory failure after multiple trauma.多发伤后呼吸衰竭患者的表面活性剂异常
Am Rev Respir Dis. 1989 Oct;140(4):1033-9. doi: 10.1164/ajrccm/140.4.1033.
3
Alveolar surfactant and adult respiratory distress syndrome. Pathogenetic role and therapeutic prospects.肺泡表面活性物质与成人呼吸窘迫综合征。发病机制作用及治疗前景。
Clin Investig. 1993 Mar;71(3):177-90. doi: 10.1007/BF00180100.
4
Composition and function of pulmonary surfactant in adult respiratory distress syndrome.成人呼吸窘迫综合征中肺表面活性物质的组成与功能
Eur Respir J Suppl. 1989 Mar;3:104s-108s.
5
Surfactant phospholipids, surfactant proteins, and inflammatory markers during acute lung injury in children.儿童急性肺损伤时的表面活性剂磷脂、表面活性剂蛋白和炎症标志物。
Pediatr Crit Care Med. 2010 Jan;11(1):82-91. doi: 10.1097/PCC.0b013e3181ae5a4c.
6
Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema.重症肺炎、急性呼吸窘迫综合征和心源性肺水肿中的表面活性剂改变。
Am J Respir Crit Care Med. 1996 Jan;153(1):176-84. doi: 10.1164/ajrccm.153.1.8542113.
7
Altered pulmonary surfactant in uncomplicated and septicemia-complicated courses of acute respiratory failure.急性呼吸衰竭单纯病程及合并败血症病程中肺表面活性物质的改变。
J Trauma. 1990 Jan;30(1):19-26. doi: 10.1097/00005373-199001000-00003.
8
Procoagulant activity in bronchoalveolar lavage in the adult respiratory distress syndrome. Contribution of tissue factor associated with factor VII.成人呼吸窘迫综合征患者支气管肺泡灌洗中的促凝活性。与凝血因子VII相关的组织因子的作用。
Am Rev Respir Dis. 1987 Dec;136(6):1466-74. doi: 10.1164/ajrccm/136.6.1466.
9
Exogenous surfactants in a piglet model of acute respiratory distress syndrome.急性呼吸窘迫综合征仔猪模型中的外源性表面活性剂
Am J Respir Crit Care Med. 1996 Feb;153(2):820-8. doi: 10.1164/ajrccm.153.2.8564138.
10
Procoagulant activity in bronchoalveolar lavage of severely traumatized patients--relation to the development of acute respiratory distress.严重创伤患者支气管肺泡灌洗中的促凝血活性——与急性呼吸窘迫发生的关系
Thromb Res. 1991 Jan 1;61(1):53-64. doi: 10.1016/0049-3848(91)90168-v.

引用本文的文献

1
Increased phospholipase A2 and lyso-phosphatidylcholine levels are associated with surfactant dysfunction in lung contusion injury in mice.在小鼠肺挫伤损伤中,增加的磷脂酶 A2 和溶磷脂酰胆碱水平与表面活性剂功能障碍有关。
Surgery. 2013 Jan;153(1):25-35. doi: 10.1016/j.surg.2012.05.043. Epub 2012 Jul 31.
2
Secretory phospholipase A2-mediated depletion of phosphatidylglycerol in early acute respiratory distress syndrome.早期急性呼吸窘迫综合征中分泌型磷脂酶 A2 介导的磷脂酰甘油耗竭。
Am J Med Sci. 2012 Jun;343(6):446-51. doi: 10.1097/MAJ.0b013e318239c96c.
3
Surfactant therapy for acute lung injury and acute respiratory distress syndrome.

本文引用的文献

1
Pulmonary surface tension and alveolar stability.肺表面张力与肺泡稳定性。
J Appl Physiol. 1961 May;16:444-50. doi: 10.1152/jappl.1961.16.3.444.
2
Surface properties in relation to atelectasis and hyaline membrane disease.与肺不张和透明膜病相关的表面特性
AMA J Dis Child. 1959 May;97(5, Part 1):517-23. doi: 10.1001/archpedi.1959.02070010519001.
3
A simple method for the isolation and purification of total lipides from animal tissues.一种从动物组织中分离和纯化总脂质的简单方法。
表面活性物质治疗急性肺损伤和急性呼吸窘迫综合征。
Crit Care Clin. 2011 Jul;27(3):525-59. doi: 10.1016/j.ccc.2011.04.005.
4
Pharmacotherapy of acute lung injury and acute respiratory distress syndrome.急性肺损伤和急性呼吸窘迫综合征的药物治疗
Curr Med Chem. 2008;15(19):1911-24. doi: 10.2174/092986708785132942.
5
Surfactant for pediatric acute lung injury.用于小儿急性肺损伤的表面活性剂
Pediatr Clin North Am. 2008 Jun;55(3):545-75, ix. doi: 10.1016/j.pcl.2008.02.016.
6
Advances in the critical care of poisoned paediatric patients.中毒儿科患者重症监护的进展。
Drug Saf. 1994 Jan;10(1):83-92. doi: 10.2165/00002018-199410010-00006.
7
Future developments in the pharmacotherapy of lung disease.
Pharm Weekbl Sci. 1992 Aug 21;14(4A):221-3. doi: 10.1007/BF01962543.
8
The surfactant system of the adult lung: physiology and clinical perspectives.成人肺的表面活性物质系统:生理学与临床视角
Clin Investig. 1992 Aug;70(8):637-57. doi: 10.1007/BF00180279.
J Biol Chem. 1957 May;226(1):497-509.
4
Evidence of lung surfactant abnormality in respiratory failure. Study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol.呼吸衰竭中肺表面活性物质异常的证据。支气管肺泡灌洗磷脂、表面活性、磷脂酶活性及血浆肌醇的研究。
J Clin Invest. 1982 Sep;70(3):673-83. doi: 10.1172/jci110662.
5
Permeability of premature lamb lungs to protein and the effect of surfactant on that permeability.早产羔羊肺对蛋白质的通透性以及表面活性剂对该通透性的影响。
J Appl Physiol Respir Environ Exerc Physiol. 1983 Jul;55(1 Pt 1):169-76. doi: 10.1152/jappl.1983.55.1.169.
6
Interactions of granulocytes with the lungs.粒细胞与肺的相互作用。
Circ Res. 1984 Jun;54(6):623-35. doi: 10.1161/01.res.54.6.623.
7
Oxygen radicals and lung edema.氧自由基与肺水肿
Physiologist. 1983 Jun;26(3):177-81.
8
Lung surfactant in an era of replacement therapy.替代疗法时代的肺表面活性物质
Pediatrics. 1981 Dec;68(6):781-9.
9
A protein from airways of premature lambs that inhibits surfactant function.
J Appl Physiol Respir Environ Exerc Physiol. 1984 Oct;57(4):1134-42. doi: 10.1152/jappl.1984.57.4.1134.
10
Isolation and quantitative estimation of pulmonary surface-active lipoprotein.
J Appl Physiol. 1966 Mar;21(2):718-20. doi: 10.1152/jappl.1966.21.2.718.